glp-1 vs sglt2 weight loss inhibitors or receptor agonists as second-line therapy in | VHRM Combining SGLT2 inhibitor and GLP-1

For the GLP1-RA group, cumulative incidence for live births, pregnancy losses and pregnancy terminations was 59%, 23% and 18%, respectively

Generic competition has pulled the overall GLP-1 drugs cost in India down sharply since semaglutides patent expired in March 2026

Alcohol consumption represents an important interaction consideration, as alcohol may increase the risk of hypoglycemia

Add fiber slowly

Thus, hepatologists should have a basic knowledge of the use of antidiabetic drugs

[4] Liraglutide has been studied most extensively in this context, with observational studies showing improvements in both weight and metabolic parameters